Entrada Therapeutics (TRDA) Cash & Current Investments (2020 - 2026)
Entrada Therapeutics (TRDA) recorded Cash & Current Investments of $99.28 million in Q2 2026, up 37.0% from $72.48 million a year earlier and up 29.9% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Entrada Therapeutics reported Cash & Current Investments of $90.39 million, down 10.7% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of 18.3% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $101.21 million in FY2024 (+49.7%), $67.6 million in FY2023 (+49.7%), $45.16 million in FY2022 (-84.5%) and $291.06 million in FY2021 (+645.5%).
- The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q4 2024.
- On a year-over-year basis, Cash & Current Investments rose in five of the last eight quarters, with growth averaging 12.1%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 645.5% in Q4 2021, against a decline of 84.5% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $76.44 million (Q1 2026), $90.39 million (Q4 2025) and $93.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Entrada Therapeutics | 186.20 Mn | -173.21 Mn | - | 99.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.28 Mn |
| Mar 31, 2026 | 76.44 Mn |
| Dec 31, 2025 | 90.39 Mn |
| Sep 30, 2025 | 93.29 Mn |
| Jun 30, 2025 | 72.48 Mn |
| Mar 31, 2025 | 67.84 Mn |
| Dec 31, 2024 | 101.21 Mn |
| Sep 30, 2024 | 78.05 Mn |
| Jun 30, 2024 | 185.25 Mn |
| Mar 31, 2024 | 68.44 Mn |
| Dec 31, 2023 | 67.60 Mn |
| Sep 30, 2023 | 51.88 Mn |
| Jun 30, 2023 | 79.74 Mn |
| Mar 31, 2023 | 227.65 Mn |
| Dec 31, 2022 | 45.16 Mn |
| Sep 30, 2022 | 215.57 Mn |
| Jun 30, 2022 | 244.25 Mn |
| Mar 31, 2022 | 263.90 Mn |
| Dec 31, 2021 | 291.06 Mn |
| Sep 30, 2021 | 122.20 Mn |
API Access
Entrada Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();